BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 32695770)

  • 1. Development and Application of CRISPR/Cas in Microbial Biotechnology.
    Ding W; Zhang Y; Shi S
    Front Bioeng Biotechnol; 2020; 8():711. PubMed ID: 32695770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas: Advances, Limitations, and Applications for Precision Cancer Research.
    Yang Y; Xu J; Ge S; Lai L
    Front Med (Lausanne); 2021; 8():649896. PubMed ID: 33748164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-cas System as a Genome Engineering Platform: Applications in Biomedicine and Biotechnology.
    Hashemi A
    Curr Gene Ther; 2018; 18(2):115-124. PubMed ID: 29473500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of CRISPR/Cas System in the Metabolic Engineering of Small Molecules.
    Singh R; Chandel S; Ghosh A; Dey D; Chakravarti R; Roy S; Ravichandiran V; Ghosh D
    Mol Biotechnol; 2021 Jun; 63(6):459-476. PubMed ID: 33774733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of CRISPR/Cas System to Bacterial Metabolic Engineering.
    Cho S; Shin J; Cho BK
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29621180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas System: Recent Advances and Future Prospects for Genome Editing.
    Manghwar H; Lindsey K; Zhang X; Jin S
    Trends Plant Sci; 2019 Dec; 24(12):1102-1125. PubMed ID: 31727474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum.
    Liu J; Wang Y; Lu Y; Zheng P; Sun J; Ma Y
    Microb Cell Fact; 2017 Nov; 16(1):205. PubMed ID: 29145843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome Editing in Bacteria: CRISPR-Cas and Beyond.
    Arroyo-Olarte RD; Bravo Rodríguez R; Morales-Ríos E
    Microorganisms; 2021 Apr; 9(4):. PubMed ID: 33920749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancing metabolic engineering of Yarrowia lipolytica using the CRISPR/Cas system.
    Shi TQ; Huang H; Kerkhoven EJ; Ji XJ
    Appl Microbiol Biotechnol; 2018 Nov; 102(22):9541-9548. PubMed ID: 30238143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous Type I CRISPR-Cas: From Foreign DNA Defense to Prokaryotic Engineering.
    Zheng Y; Li J; Wang B; Han J; Hao Y; Wang S; Ma X; Yang S; Ma L; Yi L; Peng W
    Front Bioeng Biotechnol; 2020; 8():62. PubMed ID: 32195227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harnessing CRISPR-Cas systems for bacterial genome editing.
    Selle K; Barrangou R
    Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas Technologies and Their Applications in
    Dong H; Cui Y; Zhang D
    Front Bioeng Biotechnol; 2021; 9():762676. PubMed ID: 34858961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR technologies for bacterial systems: Current achievements and future directions.
    Choi KR; Lee SY
    Biotechnol Adv; 2016 Nov; 34(7):1180-1209. PubMed ID: 27566508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Road to the future of systems biotechnology: CRISPR-Cas-mediated metabolic engineering for recombinant protein production.
    Roointan A; Morowvat MH
    Biotechnol Genet Eng Rev; 2016; 32(1-2):74-91. PubMed ID: 28052722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel nucleic acid detection strategies based on CRISPR-Cas systems: From construction to application.
    Zhu CS; Liu CY; Qiu XY; Xie SS; Li WY; Zhu L; Zhu LY
    Biotechnol Bioeng; 2020 Jul; 117(7):2279-2294. PubMed ID: 32175589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of CRISPR in a Microbial Cell Factory: From Genome Reconstruction to Metabolic Network Reprogramming.
    Wu Y; Liu Y; Lv X; Li J; Du G; Liu L
    ACS Synth Biol; 2020 Sep; 9(9):2228-2238. PubMed ID: 32794766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient expression of multiple guide RNAs for CRISPR/Cas genome editing.
    Hsieh-Feng V; Yang Y
    aBIOTECH; 2020 Apr; 1(2):123-134. PubMed ID: 36304720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application and optimization of CRISPR/Cas system in bacteria].
    Fu J; Yang F; Xie H; Gu F
    Sheng Wu Gong Cheng Xue Bao; 2019 Mar; 35(3):341-350. PubMed ID: 30912343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-Cas System: History and Prospects as a Genome Editing Tool in Microorganisms.
    Javed MR; Sadaf M; Ahmed T; Jamil A; Nawaz M; Abbas H; Ijaz A
    Curr Microbiol; 2018 Dec; 75(12):1675-1683. PubMed ID: 30078067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome Editing and Its Applications in Model Organisms.
    Ma D; Liu F
    Genomics Proteomics Bioinformatics; 2015 Dec; 13(6):336-44. PubMed ID: 26762955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.